RAQUEL SANTOS: Open Payments
NPI 1184405060 · BROOKSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,162 in 110 payments from 15 companies in 2025. Trend: 2023 $91 · 2024 $1,975 · 2025 $3,162
Food & beverage: $3,050Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $432 |
| Otsuka America Pharmaceutical, Inc. | 15 | $395 |
| Alkermes, Inc. | 11 | $355 |
| Teva Pharmaceuticals USA, Inc. | 14 | $310 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $293 |
| Neurocrine BioSciences, Inc. | 7 | $286 |
| Janssen Pharmaceuticals, Inc | 6 | $229 |
| Indivior Inc. | 6 | $216 |
| Vanda Pharmaceuticals Inc. | 8 | $188 |
| E.R. Squibb & Sons, L.L.C. | 8 | $140 |
Products named: Auvelity, CAPLYTA, INGREZZA, SUBLOCADE, REXULTI, ABILIFY MAINTENA, ARISTADA, FANAPT.
Industry payments across FL — which companies pay providers there.
